11/19/2019  9:05:19 PM Chg. -1.19 Volume Bid9:05:26 PM Ask9:05:26 PM Market Capitalization Dividend Y. P/E Ratio
56.45USD -2.06% 593,039
Turnover: 33.78 mill.
56.44Bid Size: 100 56.45Ask Size: 400 93.93 bill.USD 2.79% 19.15

Business description

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
 

Management board & Supervisory board

CEO
Giovanni Caforio, M.D.
Management board
Charles Bancroft, Adam Dubow, Ann M. Powell, Dr. Christopher Boerner, John Elicker, Joseph E. Eid, M.D., Lou Schmukler, Paul Biondi, Paul von Autenried, Samit Hirawat, M.D., Sandra Leung, Severine Lacourt
Supervisory board
Giovanni Caforio, Alan J. Lacy, Dinesh C. Paliwal, Dr. Julia A. Haller, Dr. Vicki L. Sato, Gerald L. Storch, Karen H. Vousden, Matthew W. Emmens, Michael Bonney, Michael Grobstein, Peter J. Arduini, Phyllis Yale, Robert J. Bertolini, Theodore R. Samuels
 

Company data

Name: Bristol-Myers Squibb Co.
Address: 345 Park Avenue,New York, New York 10154, USA
Phone: +1-212-546-4000
Fax: +1-212-546-4020
E-mail: -
Internet: www.bms.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 76.47%
IPO date: -

Investor relations

Name: John Elicker
IR phone: +1-609-252-4611
IR Fax: -
IR e-mail: john.elicker@bms.com

Main Shareholders

Freefloat
 
76.47%
Wellington Management Group LLP
 
8.37%
The Vanguard Group
 
8.06%
BlackRock, Inc.
 
7.10%